Security Snapshot

REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) Institutional Ownership

CUSIP: 75886F107

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

1,187

Shares (Excl. Options)

59.51MFull value: 59,506,885 · shares · 30 Sep 2026

Price

$758.27

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.03%
Share change
-373,116
Value change
-$208,979,350
Number of holders
1,187
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
103,945,862
SEC-reported price per share
$813.27
Insider filing price
$813.27
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock is tracked under CUSIP 75886F107.
  • 1187 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1,343 to 1,187 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $57.1BFull value: $57,096,629,884 · USD · 30 Jun 2026
    to
    $45.6BFull value: $45,603,759,487 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 1187 institutions filings for Q3 2026.

Open SEC evidence

Security key

75886F107

13F reference period

Q3 2026

13F holders

1,187

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
REGN
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD CAPITAL MANAGEMENT LLC 7.4% $5,919,048,238 7,660,810 Vanguard Capital Management 31 Mar 2026
JPMORGAN CHASE & CO 4.4% -14% $2,729,989,170 -$462,704,633 4,742,611 -14% JPMORGAN CHASE & CO. 30 May 2025
FMR LLC 3.2% -55% $1,880,548,739 -$2,703,197,470 3,359,563 -59% FMR LLC 30 Jun 2025
As of 30 Sep 2026, 1,187 institutional investors reported holding
59.51MFull value: 59,506,885 · shares · 30 Sep 2026
shares of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN). This represents 57% of the company’s total
103.95MFull value: 103,945,862 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
35%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 6.3% 6,522,346 0.1% $4,945,699,301
STATE STREET CORP 4.7% 4,881,362 0.11% $3,701,390,364
Dodge & Cox 4.6% 4,774,489 1.9% $3,620,351,774
Invesco Ltd. 3.6% 3,721,270 0.22% $2,821,727,063
VANGUARD PORTFOLIO MANAGEMENT LLC 3% 3,111,677 0.11% $2,359,491,319
GEODE CAPITAL MANAGEMENT, LLC 2.5% 2,632,826 0.1% $1,992,068,413
WELLINGTON MANAGEMENT GROUP LLP 1.2% 1,271,957 0.17% $964,486,836
BANK OF AMERICA CORP /DE/ 1.1% 1,166,373 0.06% $884,425,337
TWO SIGMA INVESTMENTS, LP 0.84% 869,505 0.48% $659,319,556
Capital World Investors 0.8% 832,633 0.08% $631,360,602
Legal & General Group Plc 0.67% 700,909 0.11% $531,478,265
GOLDMAN SACHS GROUP INC 0.67% 694,054 0.06% $526,280,527
DIMENSIONAL FUND ADVISORS LP 0.59% 609,644 0.08% $462,219,777
NORDEA INVESTMENT MANAGEMENT AB 0.58% 600,196 0.36% $450,591,146
VANGUARD FIDUCIARY TRUST CO 0.53% 555,992 0.09% $421,592,054
NEUBERGER BERMAN GROUP LLC 0.4% 416,347 0.22% $315,703,777
National Pension Service 0.37% 380,920 0.18% $288,840,208
ALLIANCEBERNSTEIN L.P. 0.29% 299,880 0.07% $227,388,712
WORLDQUANT MILLENNIUM ADVISORS LLC 0.27% 284,156 0.67% $215,466,970
Swiss National Bank 0.27% 281,820 0.11% $213,695,651
Bellevue Group AG 0.27% 279,590 4.4% $212,004,710
FEDERATED HERMES, INC. 0.27% 278,248 0.3% $210,987,109
RENAISSANCE TECHNOLOGIES LLC 0.26% 272,218 0.28% $206,414,743
LOS ANGELES CAPITAL MANAGEMENT LLC 0.26% 266,469 0.69% $202,055,447
Caisse de depot et placement du Quebec 0.23% 243,545 0.27% $184,672,867

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 59,506,885 $45,603,759,487 -$208,979,350 $758.27 1,187
2026 Q2 91,416,896 $57,096,629,884 +$1,614,981,745 $623.54 1,343
2026 Q1 88,782,843 $68,455,589,782 -$1,149,661,811 $772.64 1,398
2025 Q4 89,193,906 $68,857,056,243 +$1,928,512,727 $771.87 1,379
2025 Q3 86,991,990 $48,930,496,961 -$1,213,231,743 $562.27 1,235
2025 Q2 89,209,869 $46,858,212,368 -$1,426,702,234 $525.00 1,192
2025 Q1 92,030,457 $58,330,479,204 -$1,189,685,324 $634.23 1,275
2024 Q4 93,286,684 $66,492,644,189 -$479,615,848 $712.33 1,299
2024 Q3 92,775,414 $97,325,332,836 -$1,389,777,813 $1051.24 1,377
2024 Q2 94,041,724 $98,807,158,234 +$1,312,660,088 $1051.03 1,326
2024 Q1 92,759,471 $89,156,855,451 +$2,508,878,899 $962.49 1,301
2023 Q4 91,348,974 $80,250,681,450 +$167,710,733 $878.29 1,264
2023 Q3 91,165,414 $75,038,056,657 -$525,679,317 $822.96 1,169
2023 Q2 91,953,885 $66,140,528,710 -$553,052,249 $718.54 1,156
2023 Q1 92,595,818 $76,020,982,589 +$89,011,870 $821.67 1,182
2022 Q4 92,696,176 $66,864,723,638 -$266,120,511 $721.49 1,147
2022 Q3 92,906,259 $64,040,087,013 -$168,708,759 $688.87 1,066
2022 Q2 93,068,613 $55,019,554,470 +$640,020,015 $591.13 1,053
2022 Q1 92,282,918 $64,432,639,590 +$1,537,895,341 $698.42 1,082
2021 Q4 90,102,844 $56,873,192,901 +$52,711,404 $631.52 1,065
2021 Q3 90,013,397 $54,432,928,676 +$779,583,867 $605.18 1,008
2021 Q2 88,855,592 $49,577,081,270 -$361,559,165 $558.54 959
2021 Q1 89,440,318 $42,282,450,124 -$390,555,615 $473.14 906
2020 Q4 90,316,473 $43,589,271,335 -$890,178,034 $483.11 892
2020 Q3 91,983,733 $51,497,235,324 -$511,019,782 $559.78 899
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .